Cerner Corporation Company Profile (NASDAQ:CERN)

About Cerner Corporation (NASDAQ:CERN)

Cerner Corporation logoCerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company's segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States. The Global segment includes revenue contributions and expenditures linked to business activity in Aruba, Australia, Austria, the Bahamas, Belgium, Bermuda, Brazil, Canada, Cayman Islands, Chile, Denmark, Egypt, England, Finland, France, Germany, Guam, India, Ireland, Kuwait, Luxembourg, Malaysia, Mexico, the Netherlands, Norway, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovakia, Spain, Sweden, Switzerland and the United Arab Emirates. The Company's solutions are offered on the unified Cerner Millennium architecture and on the HealtheIntent cloud-based platform.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Advanced Medical Equipment & Technology
  • Sub-Industry: Health Care Technology
  • Symbol: NASDAQ:CERN
  • CUSIP: 15678210
  • Web:
  • Market Cap: $24.21 billion
  • Outstanding Shares: 331,582,000
Average Prices:
  • 50 Day Moving Avg: $70.69
  • 200 Day Moving Avg: $65.82
  • 52 Week Range: $47.01 - $73.86
  • Trailing P/E Ratio: 36.89
  • Foreward P/E Ratio: 26.26
  • P/E Growth: 1.78
Sales & Book Value:
  • Annual Revenue: $4.9 billion
  • Price / Sales: 4.94
  • Book Value: $13.14 per share
  • Price / Book: 5.56
  • EBITDA: $1.37 billion
  • Net Margins: 13.47%
  • Return on Equity: 18.18%
  • Return on Assets: 12.93%
  • Debt-to-Equity Ratio: 0.12%
  • Current Ratio: 2.39%
  • Quick Ratio: 2.37%
  • Average Volume: 1.90 million shs.
  • Beta: 0.95
  • Short Ratio: 9.43

Frequently Asked Questions for Cerner Corporation (NASDAQ:CERN)

What is Cerner Corporation's stock symbol?

Cerner Corporation trades on the NASDAQ under the ticker symbol "CERN."

How will Cerner Corporation's stock buyback program work?

Cerner Corporation declared that its board has initiated a share buyback program on Sunday, June 4th 2017, which authorizes the company to repurchase $500,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to repurchase up to 2.3% of its shares through open market purchases. Shares repurchase programs are usually an indication that the company's board of directors believes its shares are undervalued.

How were Cerner Corporation's earnings last quarter?

Cerner Corporation (NASDAQ:CERN) announced its earnings results on Thursday, July, 27th. The company reported $0.56 EPS for the quarter, missing analysts' consensus estimates of $0.57 by $0.01. The firm had revenue of $1.29 billion for the quarter, compared to the consensus estimate of $1.30 billion. Cerner Corporation had a net margin of 13.47% and a return on equity of 18.18%. The firm's revenue was up 6.3% on a year-over-year basis. During the same quarter last year, the firm posted $0.58 earnings per share. View Cerner Corporation's Earnings History.

When will Cerner Corporation make its next earnings announcement?

Cerner Corporation is scheduled to release their next quarterly earnings announcement on Thursday, October, 26th 2017. View Earnings Estimates for Cerner Corporation.

What guidance has Cerner Corporation issued on next quarter's earnings?

Cerner Corporation issued an update on its FY17 earnings guidance on Thursday, July, 27th. The company provided earnings per share guidance of $2.46-2.54 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.51. The company issued revenue guidance of $5.15-5.25 billion, compared to the consensus revenue estimate of $5.21 billion.Cerner Corporation also updated its Q3 guidance to $0.61-0.63 EPS.

Where is Cerner Corporation's stock going? Where will Cerner Corporation's stock price be in 2017?

21 equities research analysts have issued twelve-month price targets for Cerner Corporation's stock. Their forecasts range from $45.00 to $84.00. On average, they expect Cerner Corporation's share price to reach $68.39 in the next twelve months. View Analyst Ratings for Cerner Corporation.

What are analysts saying about Cerner Corporation stock?

Here are some recent quotes from research analysts about Cerner Corporation stock:

  • 1. According to Zacks Investment Research, "Earnings estimates for Cerner Corporation for the third quarter have been going down of late. The company faces currency headwind and macroeconomic challenges. Unfavorable currency translation is expected to weigh on its sales and earnings in the third quarter. In recent times System sales witnessed a major deterioration owing to a decline in technology resale. Furthermore, the HCIT market is highly competitive, which exerts considerable pressure on both pricing and margins. We believe that the company has growth opportunities in the revenue cycle management (RCM), Population Health and ambulatory markets based on its product strength and enviable track record. However, a growing proportion of low-margin services and technology resale may affect margins. Meanwhile, stringent hospital budgets exert pressure on pricing." (10/17/2017)
  • 2. Cantor Fitzgerald analysts commented, "VA to adopt Millenium. On Monday, June 5, U.S. Secretary of Veterans Affairs Dr. David J. Shulkin announced his decision to replace the Veterans Health Information Systems and Technology Architecture or VistA EHR with Cerner. VA clinicians started developing an EHR system in the 1970s which has led to VistA, the primary healthcare IT system that the VA has in place today. VistA needed to be modernized to better address cyber security challenges and keep pace with the innovations in healthcare IT. Cerner indicated in an email to the investment community that it is still early in the process and will need to negotiate a contract and choose its partners. In our view, we expect the company will not recognize the contract as bookings until 4Q17, at the earliest. DoD implementation ongoing. The DoD system, known as MHS GENESIS, is based on Cerner Millennium. MHS Genesis is currently being implemented. Cerner, along with its partners, was awarded this contract in 2015. Cerner partnered with defense computing contractor Leidos and Accenture Federal Services. We note that the DoD contract is mostly a software deal for Cerner with most implementation services being provided by Cerner’s partners. The DoD win clearly put Cerner in a strong position to win the VA contract. Part of the rationale, as stated in the VA announcement, was to put the DoD and the VA on a common platform and achieve interoperability." (6/5/2017)
  • 3. Stifel Nicolaus analysts commented, "CERN held its annual investor briefing today at the Himss conference in Orlando. The company re-iterated the financial metrics and guidance from its 4Q earnings call, which is summarized below, as well as provided updates on each of its key business initiatives. As you would expect today's briefing is more a summary of strategy and goals, which we will refer back to over the next several months. That said, there were three takeaways from today's meeting that make us on the margin more positive about the stock." (2/22/2017)

Who are some of Cerner Corporation's key competitors?

Who are Cerner Corporation's key executives?

Cerner Corporation's management team includes the folowing people:

  • Clifford W. Illig, Chairman of the Board, Interim Chief Executive Officer
  • Zane M. Burke, President
  • Marc G. Naughton, Chief Financial Officer, Executive Vice President
  • Michael R. Nill, Chief Operating Officer, Executive Vice President
  • Jeffrey A. Townsend, Chief - Staff, Executive Vice President
  • Julia M. Wilson, Chief People Officer, Executive Vice President
  • Randy D. Sims, Chief Legal Officer, Senior Vice President, Secretary
  • Mitchell E. Daniels Jr., Lead Independent Director
  • Gerald E. Bisbee Jr., Ph.D., Independent Director
  • Denis A. Cortese M.D., Independent Director

Who owns Cerner Corporation stock?

Cerner Corporation's stock is owned by a number of of retail and institutional investors. Top institutional investors include Rockefeller Financial Services Inc. (0.43%), Shell Asset Management Co. (0.02%), Arcadia Investment Management Corp MI (0.02%), Mutual of America Capital Management LLC (0.01%), Robeco Institutional Asset Management B.V. (0.01%) and Tandem Investment Advisors Inc. (0.01%). Company insiders that own Cerner Corporation stock include Clifford W Illig, Denis A Cortese, Gerald E Bisbee, Jr, Jeffrey A Townsend, Julie M Wilson, Linda M Dillman, Marc G Naughton, Michael Nill, Michael R Battaglioli, Neal L Patterson, Randy D Sims, William D Zollars and Zane M Burke. View Institutional Ownership Trends for Cerner Corporation.

Who sold Cerner Corporation stock? Who is selling Cerner Corporation stock?

Cerner Corporation's stock was sold by a variety of institutional investors in the last quarter, including Meeder Asset Management Inc., Rockefeller Financial Services Inc., Tandem Investment Advisors Inc., Arrow Financial Corp and Arcadia Investment Management Corp MI. Company insiders that have sold Cerner Corporation stock in the last year include Clifford W Illig, Denis A Cortese, Gerald E Bisbee, Jr, Jeffrey A Townsend, Julie M Wilson, Linda M Dillman, Marc G Naughton, Michael Nill, Michael R Battaglioli, Neal L Patterson, Randy D Sims, William D Zollars and Zane M Burke. View Insider Buying and Selling for Cerner Corporation.

Who bought Cerner Corporation stock? Who is buying Cerner Corporation stock?

Cerner Corporation's stock was bought by a variety of institutional investors in the last quarter, including Shell Asset Management Co., Wealth Enhancement Advisory Services LLC, Mutual of America Capital Management LLC, Robeco Institutional Asset Management B.V. and Beacon Financial Group. View Insider Buying and Selling for Cerner Corporation.

How do I buy Cerner Corporation stock?

Shares of Cerner Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cerner Corporation's stock price today?

One share of Cerner Corporation stock can currently be purchased for approximately $73.01.

MarketBeat Community Rating for Cerner Corporation (NASDAQ CERN)
Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  699 (Vote Outperform)
Underperform Votes:  393 (Vote Underperform)
Total Votes:  1,092
MarketBeat's community ratings are surveys of what our community members think about Cerner Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Cerner Corporation (NASDAQ:CERN) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 12 Hold Ratings, 8 Buy Ratings, 1 Strong Buy Rating
Consensus Rating:Hold (Score: 2.48)
Consensus Price Target: $68.39 (6.33% downside)
Consensus Price Target History for Cerner Corporation (NASDAQ:CERN)
Price Target History for Cerner Corporation (NASDAQ:CERN)
Analysts' Ratings History for Cerner Corporation (NASDAQ:CERN)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/19/2017SunTrust Banks, Inc.Reiterated RatingBuy$79.00N/AView Rating Details
10/13/2017Jefferies Group LLCSet Price TargetBuy$74.00 -> $79.00N/AView Rating Details
10/12/2017Piper Jaffray CompaniesReiterated RatingBuy$77.00N/AView Rating Details
10/10/2017Cantor FitzgeraldReiterated RatingBuy$77.00N/AView Rating Details
9/22/2017KeyCorpReiterated RatingBuy$76.00LowView Rating Details
9/19/2017Royal Bank Of CanadaInitiated CoverageTop Pick -> Top Pick$84.00LowView Rating Details
9/6/2017Canaccord GenuityReiterated RatingBuy$69.00LowView Rating Details
8/31/2017Robert W. BairdReiterated RatingHold$67.00LowView Rating Details
8/10/2017Morgan StanleyUpgradeUnderweight -> Equal Weight$59.00 -> $62.00MediumView Rating Details
7/28/2017Stifel NicolausReiterated RatingHold$69.00MediumView Rating Details
7/10/2017William BlairReiterated RatingOutperformMediumView Rating Details
6/6/2017J P Morgan Chase & CoReiterated RatingOverweight$65.00 -> $72.00LowView Rating Details
5/15/2017Bank of America CorporationUpgradeUnderperform -> Neutral$64.36 -> $66.00LowView Rating Details
5/2/2017Hilliard LyonsDowngradeBuy -> Neutral$62.00 -> $68.00MediumView Rating Details
5/1/2017Barclays PLCReiterated RatingHold$60.00LowView Rating Details
4/28/2017Leerink SwannSet Price TargetHold$65.00HighView Rating Details
2/24/2017Citigroup Inc.DowngradeBuy -> NeutralN/AView Rating Details
2/10/2017CIBCReiterated RatingOutperform -> Market PerformN/AView Rating Details
2/10/2017Oppenheimer Holdings, Inc.Reiterated RatingOutperform -> Market PerformN/AView Rating Details
2/10/2017Avondale PartnersDowngradeOutperform -> Market Perform$61.00 -> $45.00N/AView Rating Details
1/31/2017Deutsche Bank AGDowngradeBuy -> HoldN/AView Rating Details
9/8/2016Cowen and CompanyDowngradeOutperform -> Market Perform$65.00N/AView Rating Details
7/5/2016Raymond James Financial, Inc.DowngradeOutperform -> Market Perform$64.57 -> $64.57N/AView Rating Details
6/26/2016Wells Fargo & CoReiterated RatingBuyN/AView Rating Details
6/3/2016FBR & CoReiterated RatingOutperform$73.00N/AView Rating Details
5/6/2016Topeka Capital MarketsLower Price TargetBuy$65.00 -> $64.00N/AView Rating Details
2/23/2016Goldman Sachs Group, Inc. (The)DowngradeBuy -> Neutral$62.00 -> $54.00N/AView Rating Details
2/17/2016Evercore ISIDowngradeBuy -> Hold$68.00 -> $52.00N/AView Rating Details
(Data available from 10/20/2015 forward)


Earnings History for Cerner Corporation (NASDAQ:CERN)
Earnings by Quarter for Cerner Corporation (NASDAQ:CERN)
Earnings History by Quarter for Cerner Corporation (NASDAQ CERN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/26/2017$0.63N/AView Earnings Details
7/27/2017Q2 2017$0.57$0.56$1.30 billion$1.29 billionViewN/AView Earnings Details
4/27/2017Q1 17$0.53$0.59$1.23 billion$1.26 billionViewN/AView Earnings Details
2/9/2017Q416$0.61$0.61$1.26 billion$1.26 billionViewListenView Earnings Details
11/1/2016Q316$0.56$0.55$1.24 billion$1.19 billionViewListenView Earnings Details
8/2/2016Q216$0.57$0.58$1.21 billion$1.22 billionViewListenView Earnings Details
5/5/2016Q1$0.53$0.53$1.17 billion$1.14 billionViewListenView Earnings Details
2/16/2016Q4$0.57$0.61$1.17 billion$1.18 billionViewListenView Earnings Details
11/3/2015Q315$0.54$0.54$1.17 billion$1.13 billionViewListenView Earnings Details
8/4/2015Q215$0.52$0.52$1.20 billion$1.29 billionViewListenView Earnings Details
5/7/2015Q115$0.45$0.45$1.09 billion$996.10 millionViewListenView Earnings Details
2/10/2015Q414$0.47$0.47$904.60 million$926.00 millionViewListenView Earnings Details
10/23/2014Q314$0.42$0.42$855.60 million$840.00 millionViewListenView Earnings Details
7/24/2014Q214$0.40$0.40$813.77 million$851.80 millionViewListenView Earnings Details
4/24/2014Q114$0.37$0.37$784.72 million$784.80 millionViewListenView Earnings Details
2/4/2014Q413$0.39$0.39$794.22 million$793.20 millionViewListenView Earnings Details
10/24/2013Q313$0.35$0.35$757.20 million$727.80 millionViewListenView Earnings Details
7/25/2013Q2 2013$0.34$0.34$725.71 million$707.60 millionViewListenView Earnings Details
4/25/2013Q1 2013$0.63$0.66$708.43 million$680.00 millionViewListenView Earnings Details
2/5/2013Q4 2012$0.64$0.67$696.52 million$710.40 millionViewListenView Earnings Details
10/25/2012$0.59$0.60ViewN/AView Earnings Details
7/26/2012$0.54$0.59ViewN/AView Earnings Details
4/26/2012$0.50$0.54ViewN/AView Earnings Details
2/7/2012$0.52$0.55ViewN/AView Earnings Details
10/27/2011$0.47$0.48ViewN/AView Earnings Details
7/28/2011$0.43$0.44ViewN/AView Earnings Details
4/28/2011$0.76$0.80ViewN/AView Earnings Details
2/8/2011$0.84$0.87ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Cerner Corporation (NASDAQ:CERN)
2017 EPS Consensus Estimate: $2.42
2018 EPS Consensus Estimate: $2.53
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20174$0.53$0.59$0.55
Q2 20174$0.58$0.60$0.59
Q3 20174$0.58$0.66$0.62
Q4 20174$0.62$0.69$0.66
Q1 20181$0.58$0.58$0.58
Q2 20181$0.61$0.61$0.61
Q3 20182$0.64$0.65$0.65
Q4 20182$0.69$0.70$0.70
(Data provided by Zacks Investment Research)


Dividend History for Cerner Corporation (NASDAQ:CERN)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Cerner Corporation (NASDAQ:CERN)
Insider Ownership Percentage: 13.20%
Institutional Ownership Percentage: 78.94%
Insider Trades by Quarter for Cerner Corporation (NASDAQ:CERN)
Institutional Ownership by Quarter for Cerner Corporation (NASDAQ:CERN)
Insider Trades by Quarter for Cerner Corporation (NASDAQ:CERN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/13/2017Michael NillCOOSell99,470$70.45$7,007,661.50View SEC Filing  
9/5/2017Zane M. BurkePresidentSell94,000$67.47$6,342,180.00View SEC Filing  
9/1/2017Randy D SimsSVPSell60,000$68.03$4,081,800.00View SEC Filing  
8/11/2017Clifford W IlligChairmanSell118,113$62.03$7,326,549.39View SEC Filing  
6/9/2017Gerald E. Bisbee, Jr.DirectorSell6,200$67.97$421,414.00View SEC Filing  
6/7/2017Julie M. WilsonEVPSell60,000$68.15$4,089,000.00View SEC Filing  
6/6/2017Marc G. NaughtonCFOSell60,000$68.63$4,117,800.00View SEC Filing  
5/22/2017Linda M. DillmanDirectorSell4,600$64.69$297,574.00View SEC Filing  
5/12/2017Neal L PattersonChairmanSell43,000$64.33$2,766,190.00View SEC Filing  
5/11/2017Clifford W IlligVice ChairmanSell234,525$64.43$15,110,445.75View SEC Filing  
5/8/2017Neal L PattersonChairmanSell180,667$64.71$11,690,961.57View SEC Filing  
5/4/2017Denis A CorteseDirectorSell1,550$64.39$99,804.50View SEC Filing  
5/4/2017Michael NillCOOSell110,000$63.91$7,030,100.00View SEC Filing  
5/1/2017Michael R BattaglioliVPSell4,000$65.55$262,200.00View SEC Filing  
3/14/2017Neal L PattersonChairmanSell20,000$54.91$1,098,200.00View SEC Filing  
2/13/2017Jeffrey A. TownsendVPSell100,000$52.31$5,231,000.00View SEC Filing  
11/7/2016William D. ZollarsDirectorSell10,000$51.50$515,000.00View SEC Filing  
9/6/2016Linda M. DillmanDirectorSell6,000$64.68$388,080.00View SEC Filing  
8/18/2016Clifford W IlligVice ChairmanSell325,705$65.10$21,203,395.50View SEC Filing  
8/10/2016Zane M. BurkePresidentSell149,480$66.73$9,974,800.40View SEC Filing  
8/9/2016Neal L PattersonChairmanSell428,638$67.14$28,778,755.32View SEC Filing  
8/8/2016Julie M. WilsonEVPSell46,923$67.27$3,156,510.21View SEC Filing  
8/8/2016Michael NillCOOSell50,000$67.16$3,358,000.00View SEC Filing  
8/8/2016Michael R BattaglioliVPSell2,000$67.34$134,680.00View SEC Filing  
6/1/2016William D ZollarsDirectorSell9,000$55.72$501,480.00View SEC Filing  
5/23/2016Linda M DillmanDirectorSell3,700$54.46$201,502.00View SEC Filing  
5/12/2016Neal L PattersonCEOSell40,000$54.24$2,169,600.00View SEC Filing  
2/19/2016Jeffrey A. TownsendVPSell100,000$51.48$5,148,000.00View SEC Filing  
2/19/2016William D. ZollarsDirectorSell11,680$51.40$600,352.00View SEC Filing  
12/14/2015Julie M. WilsonEVPSell2,821$60.52$170,726.92View SEC Filing  
12/10/2015Michael R. BattaglioliCAOSell2,000$60.06$120,120.00View SEC Filing  
6/3/2015Clifford W IlligVice ChairmanSell20,261$67.59$1,369,440.99View SEC Filing  
6/3/2015Neal L PattersonCEOSell252,340$67.37$17,000,145.80View SEC Filing  
5/26/2015Denis A CorteseDirectorSell4,000$67.52$270,080.00View SEC Filing  
5/20/2015Gerald E Bisbee JrDirectorSell6,400$68.40$437,760.00View SEC Filing  
5/19/2015Linda M DillmanDirectorSell5,900$68.63$404,917.00View SEC Filing  
5/12/2015William D ZollarsDirectorSell7,400$67.63$500,462.00View SEC Filing  
3/9/2015Michael NillCOOSell50,000$70.45$3,522,500.00View SEC Filing  
3/2/2015Zane M BurkePresidentSell50,000$71.85$3,592,500.00View SEC Filing  
2/27/2015Jeffrey A TownsendVPSell120,000$72.13$8,655,600.00View SEC Filing  
2/25/2015Neal L PattersonCEOSell54,000$73.00$3,942,000.00View SEC Filing  
2/19/2015Randy D SimsSVPSell28,874$71.11$2,053,230.14View SEC Filing  
2/18/2015Neal L PattersonCEOSell325,492$70.06$22,803,969.52View SEC Filing  
2/13/2015Marc G NaughtonCFOSell40,000$70.95$2,838,000.00View SEC Filing  
2/13/2015Michael R BattaglioliCAOSell2,000$70.92$141,840.00View SEC Filing  
2/13/2015Randy D SimsSVPSell31,126$71.06$2,211,813.56View SEC Filing  
12/1/2014Julie M WilsonEVPSell22,000$64.58$1,420,760.00View SEC Filing  
11/26/2014Clifford W IlligChairmanSell124,084$63.44$7,871,888.96View SEC Filing  
11/25/2014Clifford W IlligChairmanSell2,900$64.50$187,050.00View SEC Filing  
11/18/2014Clifford W IlligChairmanSell116,586$64.51$7,520,962.86View SEC Filing  
11/6/2014Randy D SimsSVPSell43,162$63.65$2,747,261.30View SEC Filing  
11/4/2014Randy D SimsSVPSell26,838$63.51$1,704,481.38View SEC Filing  
11/3/2014William D ZollarsDirectorSell7,900$63.30$500,070.00View SEC Filing  
10/28/2014Michael NillCOOSell50,000$62.72$3,136,000.00View SEC Filing  
9/8/2014Julie M WilsonEVPSell16,000$59.53$952,480.00View SEC Filing  
9/3/2014Michael R BattaglioliCAOSell2,000$59.21$118,420.00View SEC Filing  
8/13/2014Neal L PattersonCEOSell54,000$56.38$3,044,520.00View SEC Filing  
8/8/2014William D ZollarsDirectorSell9,200$55.20$507,840.00View SEC Filing  
5/30/2014Denis A CorteseDirectorSell4,000$54.42$217,680.00View SEC Filing  
3/11/2014Neal PattersonCEOSell231,000$60.31$13,931,610.00View SEC Filing  
2/14/2014Neal PattersonCEOSell15,000$59.90$898,500.00View SEC Filing  
2/13/2014Michael NillCOOSell50,000$57.94$2,897,000.00View SEC Filing  
2/10/2014Michael BattaglioliCAOSell2,000$56.08$112,160.00View SEC Filing  
11/8/2013Marc NaughtonCFOSell40,000$56.57$2,262,800.00View SEC Filing  
11/7/2013Neal PattersonCEOSell4,000$55.67$222,680.00View SEC Filing  
11/1/2013Zane M BurkePresidentSell39,000$55.98$2,183,220.00View SEC Filing  
10/30/2013Michael R BattaglioliCAOSell2,400$56.85$136,440.00View SEC Filing  
9/12/2013Julie WilsonEVPSell58,000$48.57$2,817,060.00View SEC Filing  
9/12/2013Michael NillCOOSell48,320$48.77$2,356,566.40View SEC Filing  
8/1/2013Marc G NaughtonCFOSell80,000$49.50$3,960,000.00View SEC Filing  
8/1/2013Neal L PattersonCEOSell1,000$49.59$49,590.00View SEC Filing  
6/12/2013Denis A CorteseDirectorSell2,000$98.00$196,000.00View SEC Filing  
5/23/2013William D ZollarsDirectorSell10,540$95.60$1,007,624.00View SEC Filing  
5/17/2013Neal L PattersonCEOSell30,000$97.05$2,911,500.00View SEC Filing  
5/15/2013Julie M WilsonEVPSell28,000$96.61$2,705,080.00View SEC Filing  
5/14/2013Neal L PattersonCEOSell15,000$95.38$1,430,700.00View SEC Filing  
5/9/2013Jeffrey A TownsendVPSell195,664$94.98$18,584,166.72View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Cerner Corporation (NASDAQ:CERN)
Latest Headlines for Cerner Corporation (NASDAQ:CERN)
DateHeadline logoEarnings Momentum Keeps Cerner (CERN) a Buy - October 19 at 10:43 AM logoCerner Corporation (CERN) to Release Quarterly Earnings on Thursday - October 19 at 2:32 AM logoCerner Has a Bullish Setup Just Waiting for You - October 17 at 5:50 PM logoCerner Corporation (CERN) Lifted to Buy at Zacks Investment Research - October 17 at 4:02 PM logoUZA, UZ Gent and AZ Sint-Lucas Gent select Cerner for their new EHR projects - October 16 at 5:53 PM logoAMA Partners With IBM Watson, Cerner On Health Data Model - October 16 at 5:53 PM logoCerner CIO Has Helped The Company Quintuple Revenue In 12 Years - October 16 at 5:53 PM logoEdited Transcript of CERN earnings conference call or presentation 26-Jul-12 8:30pm GMT - October 15 at 4:37 PM logoEdited Transcript of CERN earnings conference call or presentation 26-Jul-12 8:30pm GMT - October 15 at 4:37 PM logoCerner Corporation (CERN) Stock Rating Reaffirmed by Piper Jaffray Companies - October 15 at 8:31 AM logoCerner Corporation (CERN) Given Average Rating of "Hold" by Brokerages - October 15 at 6:44 AM logoCerner Corporation (CERN) Stock Rating Reaffirmed by Jefferies Group LLC - October 13 at 1:24 PM logoCerner Corporation (CERN) Expected to Earn Q1 2018 Earnings of $0.58 Per Share - October 13 at 11:10 AM logoContrasting Cerner Corporation (CERN) & Invivo Therapeutics Holdings Corp (NVIV) - October 12 at 2:34 PM logoCerner's Burke: We will continue to 'fix Jeanne's record' - October 11 at 6:37 PM logoCerner Corporation (CERN) Stock Rating Reaffirmed by Cantor Fitzgerald - October 11 at 2:08 PM logoA Radical Suggestion For The Drucker Forum 2017: Implement Peter Drucker! - October 10 at 11:17 PM logoCerner to Release Third Quarter 2017 Earnings Results October 26 - GlobeNewswire (press release) - October 10 at 6:15 PM logoCerner hosts tribute to late co-founder at annual conference - October 10 at 6:15 PM logoHealthcare Analytics Market to Grow at 25.3% CAGR from 2013 to 2024: Million Insights - October 9 at 5:46 PM logoCerner to Release Third Quarter 2017 Earnings Results October 26 - October 9 at 8:52 AM logoB. Braun to Showcase Its Innovative Infusion Systems Portfolio at Cerner Health Conference 2017 - GlobeNewswire (press release) - October 6 at 10:27 PM logoB. Braun to Showcase Its Innovative Infusion Systems Portfolio at Cerner Health Conference 2017 - October 5 at 11:28 AM logoShares of Cerner (CERN) Ranked a Hold - October 5 at 10:22 AM logo$1.29 Billion in Sales Expected for Cerner Corporation (CERN) This Quarter - October 5 at 9:10 AM logoGLOBAL POPULATION HEALTH MANAGEMENT MARKET FORECAST 2017-2025 - October 4 at 3:43 PM logo Analysts Anticipate Cerner Corporation (CERN) Will Announce Earnings of $0.62 Per Share - October 3 at 8:40 AM logoTop Research Reports for Boeing, Schlumberger & JPMorgan - October 2 at 4:08 PM logoVA is expected to make Cerner deal official in the next month - October 2 at 4:08 PM logoContrasting Cerner Corporation (CERN) & The Competition - September 30 at 2:08 AM logoOncology Information System Market to Reach $3,755 Million, Globally, by 2022 - September 28 at 5:06 PM logoCerner prepares for first annual conference without Neal Patterson - September 28 at 5:06 PM logoCerner advances DoD pilot with second Navy facility - September 26 at 4:09 PM logoCerner Health Conference Welcomes Thousands of Health Care and Business Leaders to Kansas City Oct. 9-12 - September 26 at 4:09 PM logoWisconsin hospital sues Cerner for $16 million - September 25 at 7:41 PM logo3 Big Stock Charts for Thursday: Apple Inc. (AAPL),, Inc. (AMZN) and Cerner Corporation (CERN) - - September 22 at 4:05 PM logoKeyCorp Reiterates Buy Rating for Cerner Corporation (CERN) - September 22 at 6:58 AM logo3 Big Stock Charts for Thursday: Apple Inc. (AAPL),, Inc. (AMZN) and Cerner Corporation (CERN) - September 21 at 12:58 PM logoIs Cerner Corporation (CERN) Undervalued? - September 20 at 5:55 PM logoCerner Corporation (CERN) Receives Average Recommendation of "Hold" from Brokerages - September 20 at 6:34 AM logoCerner Corporation (CERN) Now Covered by Royal Bank of Canada - September 19 at 11:32 PM logoSmart Hospital Market by Component, Services Rendered, Connectivity, Application, Artificial Intelligence And Region - Global Forecast to 2023 - September 19 at 5:07 PM logoAfter Hours Most Active for Sep 18, 2017 : MSFT, LC, CERN, BAC, MU, PFE, BABA, GE, CPN, AAPL, ISBC, ETFC - Nasdaq - September 18 at 8:39 PM logoCerner Corporation (CERN) COO Sells $7,007,661.50 in Stock - September 15 at 7:24 PM logoCerner comes to Techweek KC with advice on building design and culture - September 13 at 6:16 PM logoCerner boosts severance pay for top execs - September 12 at 5:45 PM logoCerner names advisory group for VA health record overhaul - Kansas City Business Journal - September 11 at 5:43 PM logoCerner names advisory group for VA health record overhaul - September 11 at 5:43 PM logoCerner Corporation (CERN) Stock Rating Reaffirmed by Canaccord Genuity - September 10 at 10:10 PM
News Icon14 real recruiters share their favorite job interview questions - September 9 at 4:46 PM



Cerner Corporation (CERN) Chart for Friday, October, 20, 2017

This page was last updated on 10/20/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.